Literature DB >> 18514433

Myopathology of non-infectious inflammatory myopathies - the current status.

Ekkehard Hewer1, Hans H Goebel.   

Abstract

Besides the classical inflammatory myopathies (IM), dermatomyositis (DM), polymyositis, and inclusion body myositis, the much larger spectrum of IM includes focal and nodular myositis, granulomatous myositis, macrophagic myofasciitis, graft vs. host myositis, eosinophilic myositis, and other immune-associated conditions, some of them only recently described. In addition, paraneoplastic, statin-induced and critical illness myopathies have been considered immune-associated IM. Infectious, i.e., bacterial, viral, and parasitic IM are much less frequent in the northern hemisphere. In IM, muscle biopsy is an essential diagnostic procedure to initiate therapy. The myopathological spectrum encompasses disease-specific histopathological features, such as perifascicular atrophy in DM, non-necrotizing granulomas in sarcoid myopathy, autophagic vacuoles with tubulofilamentous inclusions in inclusion body myositis, rarely electron microscopic criteria, such as undulating tubules in endothelial cells of DM specimens, and, foremost, immunohistochemical findings. These latter features concern inflammatory infiltrates, the muscle parenchyma, the interstitial compartment, and the vasculature with varying involvement of each component in the different IM. Differences in immunohistochemical parameters among the IM, such as major histocompatibility complexes I and II, cytokines, cell adhesion molecules, different types of inflammatory cells, metalloproteinases, and complement factors procure a large gamut of data, the individual patterns of which characterize the myopathology of individual IM.

Entities:  

Mesh:

Year:  2008        PMID: 18514433     DOI: 10.1016/j.prp.2008.03.006

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

Review 1.  Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.

Authors:  Lisa G Rider; James D Katz; Olcay Y Jones
Journal:  Rheum Dis Clin North Am       Date:  2013-09-19       Impact factor: 2.670

2.  Major Histocompatibility Complex I and II Expression and Lymphocytic Subtypes in Muscle of Horses with Immune-Mediated Myositis.

Authors:  S A Durward-Akhurst; C J Finno; N Barnes; J Shivers; L T Guo; G D Shelton; S J Valberg
Journal:  J Vet Intern Med       Date:  2016-06-28       Impact factor: 3.333

3.  Clinical Implications and Hospital Outcome of Immune-Mediated Myositis in Horses.

Authors:  L Hunyadi; E A Sundman; P H Kass; D C Williams; M Aleman
Journal:  J Vet Intern Med       Date:  2017-01-02       Impact factor: 3.333

4.  The inflammatory pathology of dysferlinopathy is distinct from calpainopathy, Becker muscular dystrophy, and inflammatory myopathies.

Authors:  Nicole Becker; Steven A Moore; Karra A Jones
Journal:  Acta Neuropathol Commun       Date:  2022-02-08       Impact factor: 7.801

5.  Severe Thrombocytopenia in Patient with Dermatomyositis.

Authors:  A D Tudorancea; P L Ciurea; F A Vreju; E M Vintila; Ș C Dinescu
Journal:  Curr Health Sci J       Date:  2018-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.